An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
NCT01195532
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hyperglycemia
Diabetes
Sponsor
Taipei Medical University WanFang Hospital